Clinical Trial

Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary Hepatocellular carcinoma. The study will enroll approximately 500 volunteers to compare the progression-free or overall survival in patients undergoing elective partial hepatectomy for primary liver tumors between propofol and sevoflurane for the maintenance of anesthesia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-04-15; most recent amendment 2022-11-28.
Status change: Not Yet Recruiting → Recruiting 2022-11-28
Trial Details
NCT Number NCT05331911
Lead Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Collaborators: Tri-Service General Hospital (TSGH)
Conditions Hepatocellular Carcinoma
Enrollment 500 participants
Start Date 2022-04-26
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2022-11-30